This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Krismann, M. Articles by Johnen, G. Search for Related Content PubMed PubMed Citation Articles by Krismann, M. Articles by Johnen, G.

JMD 2000, Vol. 2, No. 4
Copyright © 2000 American Society for Investigative Pathology & Association for Molecular Pathology

Severe Chromosomal Aberrations in Pleural Mesotheliomas with Unusual Mesodermal Features

Comparative Genomic Hybridization Evidence for a Mesothelioma Subgroup

From the Institute of Pathology, Professional Associations’ Clinic Bergmannsheil Bochum, University Clinic, Bochum, Germany

Malignant mesotheliomas are tumors known for their extensive heterogeneity. Apart from the three classical patterns, predominantly epithelioid, sarcomatoid, and biphasic, some rare variants do exist. In some cases, one can find uncommon additional mesodermal tumor components. These tumors have previously been called "mesodermomas" and, like regular mesotheliomas, are usually associated with a previous asbestos exposure. We examined eight cases of mesodermomas by light microscopy, immunohistochemistry and comparative genomic hybridization (CGH). Besides biphasic and epithelioid areas, unusual epithelial, chondroid, osseous, or even angioblastic elements may be found to varying degrees. Immunohistochemical analysis shows similar staining results as with regular mesotheliomas. CGH reveals a high number of chromosomal imbalances (16.5 per case; range, 11–27). In 10 classical biphasic mesotheliomas that served as a control, defects of comparable number and severity could not be detected (8 per case; range, 2–16). The most frequent defects of mesodermomas (losses on 1p, 4pq, 9p, 13q, 14q, and gains on 1q and 15q), however, could also be found in mesotheliomas of the classical type. Thus, our results support the classification of the so-called mesodermomas as a separate tumor subgroup while maintaining the relationship to the classical mesotheliomas. Therefore, we propose to use the term mesodermoma for this subgroup.

This article has been cited by other articles:

				I. Opitz, A. Soltermann, M. Abaecherli, M. Hinterberger, N. Probst-Hensch, R. Stahel, H. Moch, and W. Weder PTEN expression is a strong predictor of survival in mesothelioma patients Eur. J. Cardiothorac. Surg., March 1, 2008; 33(3): 502 - 506. [Abstract] [Full Text] [PDF]

				A Scattone, A Pennella, M Gentile, M Musti, P Nazzaro, A L Buonadonna, A Marzullo, D Cavone, L Pollice, and G Serio Comparative genomic hybridisation in malignant deciduoid mesothelioma J. Clin. Pathol., July 1, 2006; 59(7): 764 - 769. [Abstract] [Full Text] [PDF]